David Meek
Voorzitter bij ENTASIS THERAPEUTICS HOLDINGS INC.
Vermogen: 140 243 $ op 31-05-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Heather Behanna | M | 49 |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | 7 jaar |
| Heather Elizabeth Preston | M | 58 | 7 jaar | |
| Manoussos Perros | M | 56 | 9 jaar | |
| Jacquelyn Sumer | F | 46 | 2 jaar | |
| Jacques Suzanne | F | 53 | 7 jaar | |
| Nadim Ahmed | M | 56 | 3 jaar | |
| Anthony Adam Rosenberg | M | 71 | 7 jaar | |
| Matt Kapusta | M | 51 | 9 jaar | |
| Madhavan Balachandran | M | 73 | 7 jaar | |
| Anne-Marie Martin | M | 52 | 2 jaar | |
| Jennifer Michaelson | M | 57 | 6 jaar | |
| Richard Porter | M | - | 3 jaar | |
| Jeannette Potts | M | 62 | - | |
| Robert Gut | M | 59 | 6 jaar | |
| Christian Klemt | M | 51 | 9 jaar | |
| David Altarac | M | 63 |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | 5 jaar |
| Margaret Liu | M | 67 | 7 jaar | |
| David Ryan | M | 57 | 2 jaar | |
| Jack Kaye | M | 80 | 8 jaar | |
| Piet Wigerinck | M | 58 | 6 jaar | |
| Jeremy Springhorn | M | 61 | 7 jaar | |
| David Hastings | M | 62 | 6 jaar | |
| Leonard Post | M | 72 | 4 jaar | |
| Thomas Ebeling | M | 65 | 7 jaar | |
| Maria E. Cantor | F | 56 | 8 jaar | |
| Stephen Webster | M | 63 | 4 jaar | |
| Rose Weldon | F | - | 2 jaar | |
| Terrell B. Jones | M | 75 |
Camping & Education Foundation
| - |
| Jeffrey Jones | M | 53 | 2 jaar | |
| Pierre Caloz | M | 52 | 3 jaar | |
| Erin Boyer | F | - | 2 jaar | |
| Matthew Ronsheim | M | 52 | 4 jaar | |
| Pavel Raifeld | M | 40 | 2 jaar | |
| Kevin Johnston | M | - | 2 jaar | |
| Corinne Savill | M | 64 | 7 jaar | |
| Stephen Andre | M | 62 | 2 jaar | |
| Chad Messer | M | - | 2 jaar | |
| Anna Diaz Triola | F | - | 3 jaar | |
| R. Douglas Rose | M | 55 |
Camping & Education Foundation
| - |
| Walid Abi-Saab | M | 59 | 1 jaar | |
| John Mueller | M | 64 | 9 jaar | |
| Ruben Tommasi | M | 58 | 9 jaar | |
| Kyle Dow | M | - | - | |
| Regis Mulot | M | 58 | 6 jaar | |
| Marianne Zhen | F | 55 | 2 jaar | |
| Aidan Murphy | M | 58 | 6 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Sander J. van Deventer | M | 69 | 22 jaar | |
| Philip Astley-Sparke | M | 51 | 8 jaar | |
| Nicholas G. Galakatos | M | 66 | 4 jaar | |
| Ludwig Hantson | M | 61 | 1 jaar | |
| Robert Hombach | M | 58 | 1 jaar | |
| Ricardo Dolmetsch | M | 55 | 3 jaar | |
| Vickie Reed | F | 62 | 9 jaar | |
| Jorge Gallardo Ballart | M | 82 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | 52 jaar |
| John Valliant | M | 54 | 10 jaar | |
| Howard Mayer | M | 61 | 4 jaar | |
| David Schaffer | M | 53 | 6 jaar | |
| Pablo Cagnoni | M | 60 | 5 jaar | |
| Scot Harper | M | 67 | 3 jaar | |
| Alex Kuta | M | 64 | 6 jaar | |
| Hélène Auriol-Potier | F | 61 | 4 jaar | |
| Paula Soteropoulos | F | 56 | 11 jaar | |
| Eva M. Mulder | F | - | 5 jaar | |
| Donald Bergstrom | M | 52 | 3 jaar | |
| Stephanie Dorn Miller | F | 50 | 1 jaar | |
| Daniel Faga | M | 44 | 1 jaar | |
| Temre Johnson | M | - | 5 jaar | |
| Sotirios G. Stergiopoulos | M | 52 | 3 jaar | |
| Carol Stuckley | F | 68 | 4 jaar | |
| Janice Murray | F | 58 |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | 13 jaar |
| Robin Isaacs | M | 65 |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | 4 jaar |
| Philina Lee | M | 47 | 3 jaar | |
| Kristie Wagner | F | 57 | - | |
| Sonia Benhamida | M | - | 7 jaar | |
| Karen Ferrante | M | 66 | 1 jaar | |
| Aaron Ondrey | M | 48 | 2 jaar | |
| Eric W. Kimble | M | 58 |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | 1 jaar |
| Hervé Couffin | M | 72 | 13 jaar | |
| Blake E. Devitt | M | 77 | 1 jaar | |
| Carol Gallagher | M | 59 | 1 jaar | |
| Francois Nader | M | 67 | 1 jaar | |
| Barbara Duncan | F | 59 | 4 jaar | |
| Lesley Russell | M | 63 | 5 jaar | |
| Christophe Jean | M | 67 | 16 jaar | |
| Gail Fosler | F | 76 | 1 jaar | |
| Albert P. L. Stroucken | M | 76 | 1 jaar | |
| Colin Goddard | M | 64 | 5 jaar | |
| John D. Forsyth | M | 76 | 1 jaar | |
| Douglas Bailey | M | 73 | 12 jaar | |
| Henry Fuchs | M | 66 | 11 jaar | |
| James R. Gavin | M | 78 | 1 jaar | |
| Pierre Martinet | M | 74 | 13 jaar | |
| Chau Khuong | M | 48 | 4 jaar | |
| Mike Gutch | M | 58 | 5 jaar | |
| Johan Rutger Christenson | M | 65 | 6 jaar | |
| Steven Gannon | M | 62 | 4 jaar | |
| Michael Seckler | M | 59 |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | 3 jaar |
| Paul Sekhri | M | 66 | 5 jaar | |
| Kathy Bodley | F | - | - | |
| Steven Zelenkofske | M | 65 | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 57 | 57.00% |
| Nederland | 23 | 23.00% |
| Frankrijk | 13 | 13.00% |
| Canada | 10 | 10.00% |
| België | 1 | 1.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- David Meek
- Persoonlijk netwerk
